Groundbreaking research links Chlamydia pneumoniae found in the retina to Alzheimer’s severity opening a new frontier in detection and treatment
A common bacteria responsible for sinus infections and pneumonia may be silently lurking in the eye for years and potentially fuelling the development of Alzheimer’s disease. That is the striking finding of a new study published in the prestigious journal Nature Communications, which could fundamentally reshape how scientists detect and treat one of the world’s most devastating neurological conditions.
Alzheimer’s disease currently affects approximately 32 million people globally, and early detection remains one of the greatest challenges in managing its progression. Scientists have long known that changes in the eye including structural alterations in the retina, blood vessel damage, and conditions such as glaucoma and cataracts may serve as early warning signals of Alzheimer’s disease. Now, researchers have discovered a compelling new piece of that puzzle.
The study, led by Professor Maya Koronyo-Hamaoui of Cedars-Sinai Medical Center, examined retinal tissue from 104 individuals ranging from healthy cognition to mild cognitive impairment to confirmed Alzheimer’s disease. Using protein analysis, genetic testing, and advanced imaging, the research team searched for levels of Chlamydia pneumoniae a bacteria commonly associated with respiratory infections within retinal tissue.
The results were striking. Retinal tissue from Alzheimer’s patients contained significantly higher levels of Chlamydia pneumoniae compared to cognitively healthy individuals.
Crucially, the higher the bacterial load, the more severe the cognitive decline a clear dose-response relationship that strengthens the biological case for infection-driven neuroinflammation as a contributor to Alzheimer’s progression.
Further laboratory studies on human neurons and a mouse model confirmed that infection with Chlamydia pneumoniaetriggered increased inflammation, nerve cell death, and cognitive decline. The bacteria also stimulated production of amyloid-beta the protein widely considered a hallmark of Alzheimer’s disease.
The implications are profound. Since the retina is accessible as central nervous system tissue, scientists believe it could eventually be monitored non-invasively offering a simpler, earlier window into Alzheimer’s detection and paving the way for entirely new treatment strategies targeting bacterial-linked neuroinflammation.
Source: medicalnewstoday
